Detection of antibodies against HLA-C epitopes in patients with rejected kidney transplants

Transplant Immunology

Volumn 24, Issue 3, 2011, Pages 164-171

  Duquesnoy, Rene J ^a   Marrari, Marilyn ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Epitope; Eplet; HLA antibody; HLAMatchmaker; Kidney transplantation

Indexed keywords

EPITOPE; HLA C ANTIGEN;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; HISTOCOMPATIBILITY; HLA MATCHING; HUMAN; IMMUNOGENICITY; IMMUNOREACTIVITY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; NEPHRECTOMY; PRIORITY JOURNAL; SEROLOGY;

ALGORITHMS; ANTIBODY FORMATION; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-C ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MODELS, MOLECULAR;

EID: 79951510496     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2010.12.003     Document Type: Article

References (28)

1. Biassoni R., Falco M., Cambiaggi A., Costa P., Verdiani S., et al. Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones. J Exp Med 1995, 182:605-609.
2. Mandelboim O., Reyburn H.T., Sheu E.G., Vales-Gomez M., Davis D.M., et al. The binding site of NK receptors on HLA-C molecules. Immunity 1997, 6:341-350.
3. Kunert K., Seiler M., Mashreghi M.F., Klippert K., Schonemann C., et al. KIR/HLA ligand incompatibility in kidney transplantation. Transplantation 2007, 84:1527-1533.
4. Hanvesakul R., Spencer N., Cook M., Gunson B., Hathaway M., et al. Donor HLA-C genotype has a profound impact on the clinical outcome following liver transplantation. Am J Transplant 2008, 8:1931-1941.
5. Tran T.H., Middleton D., Dohler B., Scherer S., Meenagh A., et al. Reassessing the impact of donor HLA-C genotype on long-term liver transplant survival.[see comment]. Am J Transplant 2009, 9:1674-1678.
6. Bonneville M., Moreau J.F., Blokland E., Pool J., Moisan J.P., et al. T lymphocyte cloning from rejected human kidney allograft. Recognition repertoire of alloreactive T cell clones. J Immunol 1988, 141:4187-4195.
7. Pei J., Akatsuka Y., Anasetti C., Lin M.T., Petersdorf E.W., et al. Generation of HLA-C-specific cytotoxic T cells in association with marrow graft rejection: analysis of alloimmunity by T-cell cloning and testing of T-cell-receptor rearrangements. Biol Blood Marrow Transplant 2001, 7:378-383.
8. Baan C.C., Vaessen L.M., ten Kate F., Schreuder G.M., Claas F.H., et al. Rejection of a kidney graft mismatched only for the HLA-C locus and an HLA-BW22 split. Transplantation 1993, 55:438-439.
9. van der Meer A., Allebes W., Paardekooper J., Ruiter J., Joosten I. HLA-C mismatched induce strong cytotoxic T-cell reactivity in the presence of an additional DRB/DQB mismatch and affect NK cell-induced mediated alloreactivity transplantation 2001, vol. 72:923-929.
10. Moya-Quiles M.R., Alvarez R., Miras M., Gomez-Mateo J., Lopez-Alvarez M.R., et al. Impact of recipient HLA-C in liver transplant: a protective effect of HLA-Cw07 on acute rejection. Hum Immunol 2007, 68:51-58.
11. Frohn C., Fricke L., Puchta J.C., Kirchner H. The effect of HLA-C matching on acute renal transplant rejection. Nephrol Dial Transplant 2001, 16:355-360.
12. Bishara A., Brautbar C., Zamir G., Eid A., Safadi R., et al. Impact of HLA-C and Bw epitopes disparity on liver transplantation outcome. Hum Immunol 2005, 66:1099-1105.
13. Petersdorf E.W., Longton G.M., Anasetti C., Mickelson E.M., McKinney S.K., et al. Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood 1997, 89:1818-1823.
14. Chapman J.R., Taylor C., Ting A., Morris P.J. Hyperacute rejection of a renal allograft in the presence of anti-HLA-Cw5 antibody. Transplantation 1986, 42:91-93.
15. Saito S., Ota S., Seshimo H., Yamazaki Y., Nomura S., et al. Platelet transfusion refractoriness caused by a mismatch in HLA-C antigens Transfusion 2002, vol. 42:302-308.
16. Bryan C., Luger A., Smith J., Warady B., Wakefield M., et al. Sharing kidneys across donor-service area boundaries with sensitized candidates can be influenced by HLA C. Clin Transplant 2010, 24:56-61.
17. Marrari M., RJ D. Detection of donor-specific HLA antibodies before and after removal of a rejected kidney transplant. Transpl Immunol 2010, 22:105-109.
18. Duquesnoy R.J. A structurally based approach to determine HLA compatibility at the humoral immune level. Hum Immunol 2006, 67:847-862.
19. El-Awar N.R., Akaza T., Terasaki P.I., Nguyen A., El-Awar N.R., et al. Human leukocyte antigen class I epitopes: update to 103 total epitopes, including the C locus. Transplantation 2007, 84:532-540.
20. El-Awar N.R., Terasaki P.I., Nguyen A., Lias M., Conger N. New HLA class I epitopes defined by murine monoclonal antibodies. Hum Immunol 2010, 71:456-461.
21. Duquesnoy R., Marrari M. Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens. Tissue Antigens 2009, 74:117-133.
22. Duquesnoy R, Mulder A, Marrari M, Mostecki J, Mulder A, et al. (Submitted for publication) Structural Aspects of HLA Class I Epitopes Reacting with Human Monoclonal Antibodies.
23. Lomago J., Jelenik L., Zern D., Howe J., Martell J., et al. How Did a Patient Who Types for HLA-B*4403 Develop Antibodies that React with HLA-B*4402?. Hum Immunol 2010, 71:176-178.
24. Duquesnoy R.J., Mulder A., Askar M., Fernandez-Vina M., Claas F.H.J. HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes. Hum Immunol 2005, 66:749-761.
25. Marrari M., Mostecki J., Mulder A., Balazs I., Claas F., et al. Human Monoclonal Antibody Reactivity with HLA Class I Epitopes Defined by Pairs of Mismatched Eplets and Self Eplets. Transplantation 2010, 90:1468-1472.
26. Dankers M.K.A., Witvliet M.D., Roelen D.L., De Lange P., Korfage N., et al. The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched HLA antigens. Transplantation 2004, 128:1236-1239.
27. Kosmoliaptsis V., Bradley J., Sharples L., Chaudhry A., Key T., et al. Predicting the immunogenicity of human leukocyte antigen class i alloantigens using structural epitope analysis determined by HLAMatchmaker. Transplantation 2008, 85:1817-1825.
28. Lobashevsky A.L., Senkbeil R.W., Shoaf J.L., Stephenson A.K., Skelton S.B., et al. The number of amino acid residues mismatches correlates with flow cytometry crossmatching results in high PRA renal patients. Hum Immunol 2002, 63:364-374.